Cytek Biosciences, Inc. (CTKB)

NASDAQ: CTKB · Real-Time Price · USD

4.360

+0.140 (3.32%)

At close: Mar 9, 2026, 4:00 PM EDT

4.510

+0.150 (3.44%)

After-hours: Mar 9, 2026, 7:35 PM EDT

Cytek Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	90.85	98.72	167.3	296.6	364.62
Short-Term Investments	170.68	179.15	95.11	44.55	-
Cash & Short-Term Investments	261.53	277.86	262.41	341.15	364.62
Cash Growth	-5.88%	5.89%	-23.08%	-6.44%	120.67%
Accounts Receivable	62.51	60.59	55.93	48.86	29.76
Inventory	-	-	60.88	48.15	32.17
Other Current Assets	19.53	14.1	12.85	15.85	5.18
Total Current Assets	392	396.45	392.06	454.02	431.73
Net Property, Plant & Equipment	29.32	28.13	29.26	27.57	5.85
Other Intangible Assets	16.82	20.13	23.08	4.33	4.74
Goodwill	16.7	16.66	16.18	10.14	10.14
Other Long-Term Assets	6.7	38.13	33.87	23.42	10.84
Total Assets	461.54	499.5	494.46	519.48	463.31
Accounts Payable	6.41	5.53	3.03	4.81	3.03
Accrued Expenses	23.42	21.44	20.04	21.13	15.25
Unearned Revenue	28.5	25.49	22.7	12.99	7.08
Other Current Liabilities	19.47	15.2	10.46	10.12	7.82
Total Current Liabilities	77.8	67.66	56.23	49.04	33.18
Long-Term Debt	0.53	1.05	1.65	2.27	-
Long-Term Leases	14.04	7.55	9.48	12.31	-
Other Long-Term Liabilities	27.43	27.5	34.04	30.31	24.74
Total Long-Term Liabilities	42	36.1	45.17	44.89	24.74
Total Liabilities	119.8	103.76	101.39	93.93	57.92
Common Stock	0.13	0.13	0.13	0.14	0.13
Additional Paid-in Capital	441.11	430.79	423.39	442.89	423.63
Accumulated Other Comprehensive Income	2.24	0.02	-1.28	-0.7	0.9
Retained Earnings	-101.74	-35.2	-29.18	-17.03	-19.61
Total Common Shareholders' Equity	341.74	395.74	393.06	425.3	405.04
Minority Interest	-	-	-	0.25	0.34
Shareholders' Equity	341.74	395.74	393.06	425.55	405.39
Total Liabilities & Equity	461.54	499.5	494.46	519.48	463.31
Total Debt	14.57	8.6	11.13	14.58	0
Net Cash (Debt)	246.96	269.26	251.28	326.57	364.62
Net Cash Growth	-8.28%	7.15%	-23.05%	-10.44%	120.67%
Net Cash Per Share	1.93	2.06	1.86	2.36	4.47
Book Value	341.74	395.74	393.06	425.3	405.04
Book Value Per Share	2.68	3.03	2.91	3.07	4.97
Tangible Book Value	308.22	358.95	353.8	410.82	390.16
Tangible Book Value Per Share	2.41	2.75	2.62	2.96	4.78

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q